Fiche centre
Strasbourg University Hospital
Strasbourg — France
Essais liés2clinical trials
VilleStrasbourglocalisation
PaysFrancelocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT04777539
Essais cliniques associés
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Tys at Home — Comparing the Safety and Benefit of Natalizumab (Tysabri®) At-home Infusion vs At-hospital Infusion in Multiple Sclerosis | SEP | À vérifier | NCT04777539 | Tys at Home — Comparing the Safety and Benefit of Natalizumab (Tysabri®) At-home Infusion vs At-hospital Infusion in Multiple Sclerosis | COMPLETED |
| Ocrelizumab | SEP | Phase 3 | NCT05210621 | CONSONANCE EX — LONG-TERM EFFECTIVENESS AND SAFETY EVALUATION OF OCRELIZUMAB | ACTIVE_NOT_RECRUITING |